image

The best stocks to buy since 1993

Latest issue now available

Xaar - Surprise profit in H2 21

February 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • XAR
  • Price:
  • 217p
The shares shot back over £2 after Xaar’s pre-close statement said it expects to report sales for FY21 of £59m, up 23% on FY20 (12% organic excluding the acquisition of FFEI). Good cost management actions mean it will report a modest profit for the second half of the year, rather than the £1.6m loss brokers had been expecting. Net cash at the year end was £25.2m. In particular, the printhead business performed well with its printheads being incorporated into a new generation of machines being designed by several customers, and FFEI (which contributed £6m to sales) has been helping in this regard. Xaar continues to successfully roll out the ImagineX platform and launched two new products - Xaar Nitrox last April and Xaar Irix in Se ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe